Literature DB >> 6279514

Uncoupled relationship between demyelination and primary infection of myelinating cells in Theiler's virus encephalomyelitis.

M C Dal Canto.   

Abstract

Theiler's virus infection in mice produces a chronic demyelinating disease which appears to be based on an immune pathogenesis rather than on direct viral destruction of myelin-supporting cells. The purpose of the present study is to ascertain whether viral antigen is present in the cytoplasm of such cells in areas of demyelination. Because of the difficulty of identifying oligodendrocytes in tissues rich in infiltrating mononuclear cells and fixed for immunohistochemistry, I turned to a recently described form of Theiler's virus encephalomyelitis which follows inoculation with the attenuated ww strain and is characterized by extensive spinal cord remyelination by invading Schwann cells and by recurrent demyelination of Schwann cell-remyelinated axons. The unlabeled antibody peroxidase-antiperoxidase technique was employed to study whether such spinal cord Schwann cells were primarily infected by virus at the time when recurrent demyelination was occurring. Whereas other types of cells, including neurons, astrocytes, and macrophages, contained abundant viral antigen, no positive immune reaction was observed in Schwann cells. These results correlate with our previous studies which had suggested that demyelination in this viral model is not dependent on primary viral attack on myelinating cells but is probably dependent on the host immune response.

Entities:  

Mesh:

Year:  1982        PMID: 6279514      PMCID: PMC351164          DOI: 10.1128/iai.35.3.1133-1138.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Multiple sclerosis. Animal model:Theiler's virus infection in mice.

Authors:  M C Dal Canto; H L Lipton
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

3.  Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies.

Authors:  Z Wroblewska; D H Gilden; M Wellish; L B Rorke; K G Warren; J S Wolinsky
Journal:  Lab Invest       Date:  1977-12       Impact factor: 5.662

4.  Pathogenesis of demyelination induced by a mouse hepatitis.

Authors:  L P Weiner
Journal:  Arch Neurol       Date:  1973-05

5.  Neuronal and oligodendroglial infection by the WW strain of Theiler's virus.

Authors:  J B Penney; J S Wolinsky
Journal:  Lab Invest       Date:  1979-03       Impact factor: 5.662

6.  Theiler's virus-induced demyelination: prevention by immunosuppression.

Authors:  H L Lipton; M C Dal Canto
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

7.  Primary demyelination in Theiler's virus infection. An ultrastructural study.

Authors:  M C Dal Canto; H L Lipton
Journal:  Lab Invest       Date:  1975-12       Impact factor: 5.662

8.  Growth of the WW strain of Theiler virus in mouse central nervous system organotypic culture.

Authors:  Z Wroblewska; S U Kim; W D Sheffield; D H Gilden
Journal:  Acta Neuropathol       Date:  1979-06-15       Impact factor: 17.088

9.  Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies.

Authors:  P W Lampert; J K Sims; A J Kniazeff
Journal:  Acta Neuropathol       Date:  1973-03-30       Impact factor: 17.088

10.  The TO strains of Theiler's viruses cause "slow virus-like" infections in mice.

Authors:  H L Lipton; M C Dal Canto
Journal:  Ann Neurol       Date:  1979-07       Impact factor: 10.422

View more
  10 in total

1.  The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.

Authors:  M Yamada; A Zurbriggen; R S Fujinami
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus.

Authors:  J E Libbey; I J McCright; I Tsunoda; Y Wada; R S Fujinami
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

3.  Localization of a neutralization site of Theiler's murine encephalomyelitis viruses.

Authors:  S Nitayaphan; M M Toth; R P Roos
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

4.  Remyelination during remission in Theiler's virus infection.

Authors:  M C Dal Canto; R L Barbano
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

5.  Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus.

Authors:  J G Pope; C L Vanderlugt; S M Rahbe; H L Lipton; S D Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 6.  Pathogenesis of Theiler's murine encephalomyelitis virus.

Authors:  M Yamada; A Zurbriggen; R S Fujinami
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

Review 7.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

Review 8.  Experimental models of virus-induced demyelination of the central nervous system.

Authors:  M C Dal Canto; S G Rabinowitz
Journal:  Ann Neurol       Date:  1982-02       Impact factor: 10.422

9.  Viruses and demyelinating disease of the central nervous system.

Authors:  R P Roos
Journal:  Neurol Clin       Date:  1983-08       Impact factor: 3.806

10.  Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection.

Authors:  H Wege; R Watanabe; V ter Meulen
Journal:  J Neuroimmunol       Date:  1984-08       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.